awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51481656-06FC840D-77CE-4683-A287-A83D419D9BBB
Q51481656-06FC840D-77CE-4683-A287-A83D419D9BBB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51481656-06FC840D-77CE-4683-A287-A83D419D9BBB
Once-daily abacavir/lamivudine/zidovudine plus tenofovir for the treatment of HIV-1 infection in antiretroviral-naïve subjects: a 48-week pilot study.
P2860
Q51481656-06FC840D-77CE-4683-A287-A83D419D9BBB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51481656-06FC840D-77CE-4683-A287-A83D419D9BBB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bddb65cac9e9f942b960d0f8ee682b1a785fc995
P2860
Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.